Stocks and Investing Stocks and Investing
Tue, November 1, 2022
[ 12:00 AM ] - WOPRAI
Saket Kalia Maintained (VRNS) at Hold with Decreased Target to $22 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Alex Henderson Maintained (VRNS) at Strong Buy with Decreased Target to $26 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Daniel Ives Downgraded (VRNS) to Hold and Decreased Target to $20 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Erik Suppiger Maintained (VRNS) at Buy with Decreased Target to $63 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Hamza Fodderwala Maintained (VRNS) at Hold with Decreased Target to $22 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (VRNS) at Buy with Decreased Target to $29 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Shaul Eyal Maintained (VRNS) at Buy with Decreased Target to $35 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Joel Fishbein Maintained (VRNS) at Strong Buy with Decreased Target to $40 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Chad Bennett Downgraded (VRNS) to Hold and Decreased Target to $22 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Fatima Boolani Downgraded (VRNS) to Hold and Held Target at $21 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Omar Nokta Maintained (STNG) at Strong Buy with Increased Target to $60 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Kyle Rose Downgraded (SYK) to Hold and Decreased Target to $220 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Shagun Singh Maintained (SYK) at Hold with Decreased Target to $240 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Larry Biegelsen Maintained (SYK) at Buy with Increased Target to $248 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Lucas Herrmann Upgraded (XOM) to Hold and Held Target at $115 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Brian Ossenbeck Maintained (XPO) at Buy with Decreased Target to $74 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Etzer Darout Maintained (YMAB) at Buy with Decreased Target to $12 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (TDC) at Strong Buy with Decreased Target to $40 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (TCS) at Sell with Decreased Target to $75 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Salim Syed Maintained (BIIB) at Strong Buy with Increased Target to $325 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Maintained (CCCS) at Hold with Decreased Target to $10 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
John Roberts Initiated (CC) at Sell and Held Target at $24 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Paul Quinn Downgraded (CLW) to Hold and Held Target at $45 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Mark Wilde Maintained (CLW) at Buy with Increased Target to $52 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
John Eade Maintained (SPGI) at Strong Buy with Decreased Target to $365 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (DOC) at Hold with Decreased Target to $15 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Maintained (SPOT) at Hold with Decreased Target to $87 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Yaron Werber Downgraded (TIL) to Hold on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Jack Allen Maintained (TIL) at Buy with Decreased Target to $480 on, Nov 1st, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (TIL) at Hold with Decreased Target to $120 on, Nov 1st, 2022

Vikram Purohit Maintained (TIL) at Hold with Decreased Target to $120 on, Nov 1st, 2022


Published on 2024-10-27 23:48:45 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Instil Bio, Inc." (TIL) at Hold with Decreased Target from $160 to $120 on, Nov 1st, 2022.

Vikram has made no other calls on TIL in the last 4 months.



There is 1 other peer that has a rating on TIL. Out of the 1 peers that are also analyzing TIL, 0 agree with Vikram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Vikram

  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, August 23rd, 2022
Contributing Sources